紫色马铃薯酒发酵工艺优化及主发酵期花青素与色泽的动态变化

以紫色马铃薯为原料，在单因素的基础上，通过响应面法对紫色马铃薯酒的发酵工艺参数进行优化。最佳发酵工艺参数为:马铃薯与面粉比1:0.6、料水比1:1 (g/mL)、α-淀粉酶添加量8.5 U/g、酒曲添加量0.45%。此工艺在28 ℃下发酵14 d，得到的紫色马铃薯酒酒精度13.5%vol，花青素含量166.34 mg/mL，酒体澄清透明呈紫红色，酸甜适中，有独特酒香，综合感官评定得分90分。测定主发酵期花青素和色泽的动态变化，分析表明，紫色马铃薯酒在发酵过程中花青素呈现先上升后下降的趋势，色度呈现先下降后趋于平缓的趋势，色调则与之相反。聚合色度和褐变指数总体均呈现逐渐上升的趋势。试验结果为工业化生产紫色马铃薯酒提供理论依据。     

基于Freescale的水质氨氮检测系统的设计

针对水质污染情况的严重性和水质主要污染源之一的氨氮缺乏实时检测的情况，设计了一套基于Freescale单片机芯片的水质氨氮检测系统，可以实时和快速地计算出水质中氨氮的含量。检测系统的硬件部分设计主要包括微处理器模块、温度控制模块、存储模块、信号采集模块以及通信模块的电路设计，软件部分对不同的模块进行程序设计以及上位机软件平台的开发。最后对整个系统进行实验测试，实验结果表明检测系统可以满足氨氮检测的精度要求。     

Preliminary Evidence on the Diagnostic and Molecular Role of Circulating Soluble EGFR in Non-Small Cell Lung Cancer

Assessment of biological diagnostic factors providing clinically-relevant information to guide physician decision-making are still needed for diseases with poor outcomes, such as non-small cell lung cancer (NSCLC). Epidermal growth factor receptor (EGFR) is a promising molecule in the clinical management of NSCLC. While the EGFR transmembrane form has been extensively investigated in large clinical trials, the soluble, circulating EGFR isoform (sEGFR), which may have a potential clinical use, has rarely been considered. This study investigates the use of sEGFR as a potential diagnostic biomarker for NSCLC and also characterizes the biological function of sEGFR to clarify the molecular mechanisms involved in the course of action of this protein. Plasma sEGFR levels from a heterogeneous cohort of 37 non-advanced NSCLC patients and 54 healthy subjects were analyzed by using an enzyme-linked immunosorbent assay. The biological function of sEGFR was analyzed in vitro using NSCLC cell lines, investigating effects on cell proliferation and migration. We found that plasma sEGFR was significantly decreased in the NSCLC patient group as compared to the control group (median value: 48.6 vs. 55.6 ng/mL respectively; p = 0.0002). Moreover, we demonstrated that sEGFR inhibits growth and migration of NSCLC cells in vitro through molecular mechanisms that included perturbation of EGF/EGFR cell signaling and holoreceptor internalization. These data show that sEGFR is a potential circulating biomarker with a physiological protective role, providing a first approach to the functional role of the soluble isoform of EGFR. However, the impact of these data on daily clinical practice needs to be further investigated in larger prospective studies.     

开关磁阻直线电机的设计及其推力优化

设计了一种开关磁阻直线电机,使用JMAG软件对其进行了仿真和优化。进行了推力公式的推导,研究了导通顺序和初始位置对电机推力的影响,并分析了三种典型情况的磁力线分布。对电机的定子和动子的齿部和轭部高度、宽度及铁耗进行仿真优化,得出了最优参数。将有取向硅钢应用于该电机,研究了推力与轧制角的关系,并与使用普通硅钢的开关磁阻直线电机进行了对比,推力有一定提升。提出在动子齿部开切向槽的方案,结果表明,开切向槽对推力的影响较小,并能显著减小推力波动。     

超声波探伤在铝合金中厚板检测中的应用

文章介绍了铝合金中厚板内部的常见缺陷,比较了超声波探伤铝合金中厚板的常用方法,展望了铝板超声波探伤未来的发展。     

子母车系统效率分析与验证

在子母车系统中,研究一台母车配合两台子车在同层进行复合作业的效率问题,提高系统作业效率计算的准确性,优化系统整体布局和物流设备的选择。首先分析一台母车配合两台子车在同层的循环复合作业过程;然后结合子母车的运动特性得到其作业效率计算模型;最后采用MATLAB工具计算效率模型分别在随机组合作业对和FEM9.851标准作业对的作业效率,通过对比验证,两种循环作业的效率绝对偏差符合工程实际。在工程实际中可以参照FEM9.851标准作业对代替随机组合作业对进行子母车系统的效率计算。     

液压支架让缩性能试验特性分析与探讨

分析研究国家标准中液压支架让缩性能试验的技术要求,设计开发让缩性能试验系统,以双伸缩立柱液压支架为研究对象进行让缩性能试验分析与研究,为让缩性能试验的开展提供了试验条件,为液压支架国标的实施提供基础。     

PET的紫外老化性能及机理研究

采用力学、紫外-可见光分析和热失质等测试手段研究了PET改性料的紫外老化性能及老化机理。结果表明:复合助剂的加入能显著提升体系的力学性能保持率,进而提升其紫外老化寿命,提升的幅度随复合助剂中耐紫外剂含量的增加而显著增加。DSC分析表明,随着复合助剂的引入和老化的进行,改性料结晶度增加。文中进一步讨论了PET改性料的紫外老化机理。紫外-可见光分析表明,紫外老化能产生醌类和双醌类物质,进而提升PET改性料的紫外吸收度。     

K4,4,p的点可区别的IE-全染色(p≥1008)

该文利用色集事先分配法、构造染色法、反证法探讨了完全三部图K_4,4,p (p≥1008)的点可区别IE-全染色问题，确定了K_4,4,p (p≥1008)的点可区别IE-全染色数。     

Microenvironment and related genes predict outcomes of patients with cervical cancer: evidence from TCGA and bioinformatic analysis

Cervical cancer (CESC) is one of the most common cancers and affects the female genital tract. Consistent HPV infection status has been determined to be a vital cause of tumorigenesis. HPV infection may induce changes to the immune system and limit the host’s immune response. Immunotherapy is therefore essential to improving the overall survival of both locally advanced and recurrent CESC patients. Using 304 relevant samples from TCGA, we assessed immune cell function in CESC patients to better understand the status of both tumor micro-environment cells and immune cells in CESC. Functional enrichment analysis, pathway enrichment analysis, and PPI network construction were performed to explore the differentially expressed genes (DEGs). The analysis identified 425 DEGs, which included 295 up-regulated genes and 130 down-regulated genes. We established that upregulation of CCL5 was correlated with significantly better survival, meaning that CCL5 expression could serve as a novel prognostic biomarker for CESC patients. We further focused on CCL5 as a hub gene in CESC, as it had significant correlations with increased numbers of several types of immune cells. Cell-type fractions of M1 macrophages were significantly higher in the high-immune-scores group, which was associated with better overall survival. Finally, we concluded that CCL5 is a promising prognostic biomarker for CESC, as well as a novel chemotherapeutic target.